精准肿瘤学检测使用中基于遗传血统的差异 - Suppr

Suppr

超能文献

Disparities According to Genetic Ancestry in the Use of Precision Oncology Assays.

作者信息

Mata Douglas A, Rotenstein Lisa S, Ramos Marco A, Jena Anupam B

机构信息

Foundation Medicine, Cambridge, MA

Harvard Medical School, Boston, MA.

出版信息

N Engl J Med. 2023 Jan 19;388(3):281-283. doi: 10.1056/NEJMc2213457.

DOI:10.1056/NEJMc2213457

PMID:36652362

Abstract

摘要

相似文献

Disparities According to Genetic Ancestry in the Use of Precision Oncology Assays.

N Engl J Med. 2023 Jan 19;388(3):281-283. doi: 10.1056/NEJMc2213457.

Diversity and Inclusion in Cancer Research and Oncology.

Trends Cancer. 2020 Sep;6(9):719-723. doi: 10.1016/j.trecan.2020.07.003. Epub 2020 Aug 13.

Precision oncology: Directing genomics and pharmacogenomics toward reducing cancer inequities.

Cancer Cell. 2021 Jun 14;39(6):730-733. doi: 10.1016/j.ccell.2021.04.013. Epub 2021 May 20.

The science of precision prevention of cancer.

Lancet Oncol. 2017 Aug;18(8):997-998. doi: 10.1016/S1470-2045(17)30331-5. Epub 2017 Jul 26.

Biological Aspects of Cancer Health Disparities.

Annu Rev Med. 2021 Jan 27;72:229-241. doi: 10.1146/annurev-med-070119-120305.

Precision Oncology: Are We There Yet?

EBioMedicine. 2017 Apr;18:1-2. doi: 10.1016/j.ebiom.2017.04.023.

Precision oncology: East meets West.

Int J Cancer. 2018 May 1;142(9):1734-1737. doi: 10.1002/ijc.31218. Epub 2018 Jan 4.

Next-Generation Sequencing in Oncology in the Era of Precision Medicine.

JAMA Oncol. 2016 Jan;2(1):13-4. doi: 10.1001/jamaoncol.2015.4503.

CRISPR-Cas13a system: a novel approach to precision oncology.

Cancer Biol Med. 2020 Feb 15;17(1):6-8. doi: 10.20892/j.issn.2095-3941.2019.0325.

20 years of precision medicine in oncology.

Lancet. 2021 May 15;397(10287):1781. doi: 10.1016/S0140-6736(21)01099-0.

引用本文的文献

Defining a 'cells to society' research framework for appendiceal tumours.

Nat Rev Cancer. 2025 Apr;25(4):293-315. doi: 10.1038/s41568-024-00788-2. Epub 2025 Feb 20.

Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types.

J Immunother Cancer. 2025 Feb 6;13(2):e010311. doi: 10.1136/jitc-2024-010311.

Molecular Profiling of Biliary Tract Cancers in African American and Caucasian Patients.

JCO Precis Oncol. 2025 Jan;9:e2400712. doi: 10.1200/PO-24-00712. Epub 2025 Jan 7.

Using multiplexed functional data to reduce variant classification inequities in underrepresented populations.

Genome Med. 2024 Dec 3;16(1):143. doi: 10.1186/s13073-024-01392-7.

Ancestral Differences in Anticancer Treatment Efficacy and Their Underlying Genomic and Molecular Alterations.

Cancer Discov. 2025 Mar 3;15(3):511-529. doi: 10.1158/2159-8290.CD-24-0827.

Clinical value of comprehensive genomic profiling on clinical trial enrollment for patients with advanced solid tumors.

Oncologist. 2025 Jul 4;30(7). doi: 10.1093/oncolo/oyae293.

Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers.

JAMA Netw Open. 2024 Jul 1;7(7):e2423186. doi: 10.1001/jamanetworkopen.2024.23186.

Aspiring toward equitable benefits from genomic advances to individuals of ancestrally diverse backgrounds.

Am J Hum Genet. 2024 May 2;111(5):809-824. doi: 10.1016/j.ajhg.2024.04.002. Epub 2024 Apr 19.

Characterization of Thyroid Cancer among Hispanics in California, USA, from 2010 to 2020.

Cancers (Basel). 2024 Mar 8;16(6):1101. doi: 10.3390/cancers16061101.

Trends and age, sex, and race disparities in time to second primary cancer from 1990 to 2019.

Cancer Med. 2023 Dec;12(24):22316-22324. doi: 10.1002/cam4.6785. Epub 2023 Dec 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Disparities According to Genetic Ancestry in the Use of Precision Oncology Assays.

N Engl J Med. 2023 Jan 19;388(3):281-283. doi: 10.1056/NEJMc2213457.

Diversity and Inclusion in Cancer Research and Oncology.

Trends Cancer. 2020 Sep;6(9):719-723. doi: 10.1016/j.trecan.2020.07.003. Epub 2020 Aug 13.

Precision oncology: Directing genomics and pharmacogenomics toward reducing cancer inequities.

Cancer Cell. 2021 Jun 14;39(6):730-733. doi: 10.1016/j.ccell.2021.04.013. Epub 2021 May 20.

The science of precision prevention of cancer.

Lancet Oncol. 2017 Aug;18(8):997-998. doi: 10.1016/S1470-2045(17)30331-5. Epub 2017 Jul 26.

Biological Aspects of Cancer Health Disparities.

Annu Rev Med. 2021 Jan 27;72:229-241. doi: 10.1146/annurev-med-070119-120305.

Precision Oncology: Are We There Yet?

EBioMedicine. 2017 Apr;18:1-2. doi: 10.1016/j.ebiom.2017.04.023.

Precision oncology: East meets West.

Int J Cancer. 2018 May 1;142(9):1734-1737. doi: 10.1002/ijc.31218. Epub 2018 Jan 4.

Next-Generation Sequencing in Oncology in the Era of Precision Medicine.

JAMA Oncol. 2016 Jan;2(1):13-4. doi: 10.1001/jamaoncol.2015.4503.

CRISPR-Cas13a system: a novel approach to precision oncology.

Cancer Biol Med. 2020 Feb 15;17(1):6-8. doi: 10.20892/j.issn.2095-3941.2019.0325.

20 years of precision medicine in oncology.

Lancet. 2021 May 15;397(10287):1781. doi: 10.1016/S0140-6736(21)01099-0.

引用本文的文献

Defining a 'cells to society' research framework for appendiceal tumours.

Nat Rev Cancer. 2025 Apr;25(4):293-315. doi: 10.1038/s41568-024-00788-2. Epub 2025 Feb 20.

Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types.

J Immunother Cancer. 2025 Feb 6;13(2):e010311. doi: 10.1136/jitc-2024-010311.

Molecular Profiling of Biliary Tract Cancers in African American and Caucasian Patients.

JCO Precis Oncol. 2025 Jan;9:e2400712. doi: 10.1200/PO-24-00712. Epub 2025 Jan 7.

Using multiplexed functional data to reduce variant classification inequities in underrepresented populations.

Genome Med. 2024 Dec 3;16(1):143. doi: 10.1186/s13073-024-01392-7.

Ancestral Differences in Anticancer Treatment Efficacy and Their Underlying Genomic and Molecular Alterations.

Cancer Discov. 2025 Mar 3;15(3):511-529. doi: 10.1158/2159-8290.CD-24-0827.

Clinical value of comprehensive genomic profiling on clinical trial enrollment for patients with advanced solid tumors.

Oncologist. 2025 Jul 4;30(7). doi: 10.1093/oncolo/oyae293.

Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers.

JAMA Netw Open. 2024 Jul 1;7(7):e2423186. doi: 10.1001/jamanetworkopen.2024.23186.

Aspiring toward equitable benefits from genomic advances to individuals of ancestrally diverse backgrounds.

Am J Hum Genet. 2024 May 2;111(5):809-824. doi: 10.1016/j.ajhg.2024.04.002. Epub 2024 Apr 19.

Characterization of Thyroid Cancer among Hispanics in California, USA, from 2010 to 2020.

Cancers (Basel). 2024 Mar 8;16(6):1101. doi: 10.3390/cancers16061101.

Trends and age, sex, and race disparities in time to second primary cancer from 1990 to 2019.

Cancer Med. 2023 Dec;12(24):22316-22324. doi: 10.1002/cam4.6785. Epub 2023 Dec 8.